Synthetic peptides fail to induce nasal tolerance to experimental autoimmune myasthenia gravis. (Q47973605)

7 February 2018

title

Synthetic peptides fail to induce nasal tolerance to experimental autoimmune myasthenia gravis. (English)

1 reference

7 February 2018

0 references

6

Wahren B

1 reference

7 February 2018

author name string

Zhang GX

1

1 reference

7 February 2018

Shi FD

2

1 reference

7 February 2018

Zhu J

3

1 reference

7 February 2018

Xiao BG

4

1 reference

7 February 2018

Levi M

5

1 reference

7 February 2018

Yu LY

7

1 reference

7 February 2018

Link H

8

1 reference

7 February 2018

publication date

1 May 1998

1 reference

7 February 2018

Journal of Neuroimmunology

published in

1 reference

7 February 2018

volume

85

1 reference

7 February 2018

issue

1

1 reference

7 February 2018

page(s)

96-101

1 reference

7 February 2018

Prevention of experimental autoimmune myasthenia gravis by manipulation of the immune network with a complementary peptide for the acetylcholine receptor

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900243-9

7 January 2021

T-cell epitopes on the human acetylcholine receptor alpha-subunit residues 10-84 in myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900243-9

7 January 2021

Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900243-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900243-9

1 reference

7 January 2021

Autoimmune T cells in myasthenia gravis: heterogeneity and potential for specific immunotargeting

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900243-9

7 January 2021

29 Production and assay of antibodies to acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900243-9

7 January 2021

The T-cell repertoire in myasthenia gravis involves multiple cholinergic receptor epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900243-9

7 January 2021

Passive transfer of experimental myasthenia gravis via antigenic modulation of acetylcholine receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900243-9

7 January 2021

Suppression of experimental autoimmune myasthenia gravis by nasal administration of acetylcholine receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900243-9

7 January 2021

Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900243-9

7 January 2021

Oral administration of acetylcholine receptor: effects on experimental myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900243-9

7 January 2021

Antibody avidity determination by ELISA using thiocyanate elution.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900243-9

7 January 2021

Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal tolerance to synthetic region alpha 146-162 of acetylcholine receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900243-9

7 January 2021

Modulation of anti-acetylcholine receptor antibody specificities and of experimental autoimmune myasthenia gravis by synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900243-9

7 January 2021

Induction of tolerance in experimental autoimmune myasthenia gravis with solubilized MHC class II:acetylcholine receptor peptide complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900243-9

7 January 2021

Mucosal tolerance and suppression of collagen-induced arthritis (CIA) induced by nasal inhalation of synthetic peptide 184-198 of bovine type II collagen (CII) expressing a dominant T cell epitope

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900243-9

7 January 2021

Myasthenogenic significance of synthetic alpha-subunit peptide 183-200 of Torpedo californica and human acetylcholine receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900243-9

7 January 2021

V beta-specific immunotoxin selectively kills acetylcholine receptor-reactive T lymphocytes from mice with experimental autoimmune myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900243-9

7 January 2021

T cell reactivity to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900243-9

7 January 2021

B cell responses to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900243-9

7 January 2021

Antigen-specific immunotherapy of autoimmune disease: a commentary

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900243-9

7 January 2021

T cell epitopes in experimental autoimmune myasthenia gravis of the rat: strain-specific epitopes and cross-reaction between two distinct segments of the alpha chain of the nicotinic acetylcholine receptor (Torpedo californica)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900243-9

7 January 2021

Autoreactive T cell responses and cytokine patterns reflect resistance to experimental autoimmune myasthenia gravis in Wistar Furth rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900243-9

7 January 2021

Neonatal tolerance to an immunodominant T cell reactivity does not confer resistance to EAMG induction in Lewis rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900243-9

7 January 2021

10.1016/S0165-5728(97)00243-9

Identifiers

DOI

1 reference

7 February 2018

PubMed ID

9627002

1 reference

7 February 2018